Teneligliptin hydrobromide hydrate |
Catalog No.GC37757 |
El hidrato de bromhidrato de teneligliptina es un potente inhibidor de DPP-4 basado en quimiotipo proliltiazolidina, que inhibe de manera competitiva el plasma humano, el plasma de rata y la DPP-4 recombinante humana in vitro, con IC50 de aproximadamente 1 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1572583-29-9
Sample solution is provided at 25 µL, 10mM.
Teneligliptin hydrobromide hydrate is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM[1].
[1]. Fukuda-Tsuru S, et al. A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations. Eur J Pharmacol. 2012 Dec 5;696(1-3):194-202.
Average Rating: 5
(Based on Reviews and 37 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *